Yaqian Han Selected Research

MicroRNAs (MicroRNA)

4/2020	Exosomal miRNAs in tumor microenvironment.
1/2020	MiRNAs in Radiotherapy Resistance of Nasopharyngeal Carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yaqian Han Research Topics

Disease

21	Neoplasms (Cancer) 01/2024 - 01/2016
9	Nasopharyngeal Carcinoma 12/2023 - 09/2017
6	Neoplasm Metastasis (Metastasis) 12/2023 - 01/2020
4	Carcinogenesis 12/2023 - 01/2020
2	Head and Neck Neoplasms (Head and Neck Cancer) 02/2024 - 10/2020
2	Hypoxia (Hypoxemia) 01/2022 - 01/2021
2	Lung Neoplasms (Lung Cancer) 01/2020 - 01/2016
2	Hypertension (High Blood Pressure) 09/2017 - 01/2017
1	Neurocognitive Disorders (Clerambault Syndrome) 01/2024
1	Seizures (Absence Seizure) 01/2023
1	Emergence Delirium 09/2022
1	Hypospadias 09/2022
1	Hyperthermia 01/2022
1	Colonic Neoplasms (Colon Cancer) 01/2022
1	Pain (Aches) 01/2022
1	Postpartum Depression (Post-Natal Depression) 01/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2022
1	Lymphatic Metastasis 01/2021
1	Acidosis 01/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2020
1	Squamous Cell Carcinoma of Head and Neck 10/2020
1	Alzheimer Disease (Alzheimer's Disease) 01/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020
1	Parkinson Disease (Parkinson's Disease) 01/2020
1	Huntington Disease (Huntington's Disease) 01/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017

Drug/Important Bio-Agent (IBA)

4	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 05/2019
3	Sevoflurane (Ultane)FDA LinkGeneric 01/2024 - 09/2022
3	Proteins (Proteins, Gene)FDA Link 12/2023 - 01/2019
2	Amino Acids FDA Link 01/2024 - 01/2023
2	IronIBA 01/2024 - 01/2024
2	LipidsIBA 01/2024 - 01/2023
2	ProhibitinsIBA 03/2023 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2021
2	Oxygen (Dioxygen)IBA 01/2022 - 05/2019
2	CytokinesIBA 01/2022 - 04/2020
2	MicroRNAs (MicroRNA)IBA 04/2020 - 01/2020
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2017 - 01/2017
1	nimotuzumabIBA 02/2024
1	SeleniumIBA 01/2024
1	Isoflurane FDA LinkGeneric 01/2024
1	NF-kappa B (NF-kB)IBA 12/2023
1	CateninsIBA 12/2023
1	Cisplatin (Platino)FDA LinkGeneric 01/2023
1	Histones (Histone)IBA 01/2023
1	Docetaxel (Taxotere)FDA Link 01/2023
1	Matrix Metalloproteinases (MMPs)IBA 03/2022
1	EsketamineIBA 01/2022
1	hydroxide ionIBA 01/2022
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022
1	Fructose-Bisphosphate Aldolase (Aldolase)IBA 01/2022
1	SmokeIBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	Tuberculin (PPD)IBA 01/2022
1	Hydroxyl RadicalIBA 01/2022
1	SurvivinIBA 01/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2021
1	Arginine (L-Arginine)FDA Link 01/2021
1	Dinoprostone (PGE2)FDA Link 01/2021
1	ErbB Receptors (EGF Receptor)IBA 10/2020
1	Carrier Proteins (Binding Protein)IBA 01/2020
1	prefoldinIBA 01/2020
1	Biocompatible Materials (Biomaterials)IBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 05/2019
1	CalreticulinIBA 01/2019
1	Propranolol (Inderal)FDA LinkGeneric 01/2017
1	VimentinIBA 01/2016
1	ParaffinIBA 01/2016
1	Botulinum Toxins (Botulinum Toxin)IBA 01/2016
1	Cadherins (E-Cadherin)IBA 01/2016

Therapy/Procedure

9	Therapeutics 01/2024 - 10/2020
8	Radiotherapy 02/2024 - 01/2016
4	Chemoradiotherapy 02/2024 - 01/2017
3	Drug Therapy (Chemotherapy) 08/2023 - 05/2019
2	Induction Chemotherapy 12/2022 - 01/2022
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 12/2023
1	Anesthesia 09/2022
1	Pediatric Anesthesia 09/2022
1	Cannula 01/2022
1	Analgesia 01/2022
1	Cesarean Section (Caesarean Section) 01/2022
1	Immunotherapy 01/2021